Vyvanse New ADHD Treatment Medication for Children - Vyvanse

Thu, 13 Sep 2007 00:16:51 +0000

A new ADHD treatment medication, Vyvanse (lisdexamfetamine dimesylate), provides consistent ADHD symptom control for children for up to 12 hours. ... LDX531 07/07 ...

Vyvanse
Vyvanse (lisdexamfetamine dimesylate) is designed as a capsule for once-a-day oral ... Scale (ADHD-RS), were observed at endpoint for all Vyvanse doses ...

Shire Receives Approval Letter for VYVANSE_ (lisdexamfetamine dimesylate) for the Treatment of ADHD
... are pleased with the results of VYVANSE studies conducted in adults and we ... VYVANSE is a priority in our ADHD portfolio and we are committed to developing ...

Frequently Asked Questions (FAQ) - Vyvanse
Frequently asked question about Vyvanse (lisdexamfetamine dimesylate) for treatment of ... were some key findings about Vyvanse' Why is consistent ADHD symptom ...

Vyvanse
Vyvanse, an FDA-approved treatment for children with ADHD, became available in July 2007. ... Childhood Medications> Drug Profiles> ADHD Medicines> Vyvanse ......

And the ones that mother gives you - Toronto Star

Sun, 09 Sep 2007 23:15:46 +0000

And the ones that mother gives you
Toronto Star, Canada -Aug 22, 2007
"Consistent Kevin" and "Consistent Sarah" are the poster kids in the magazine ads for Vyvanse, the new drug on the market for ADHD. ...

ADHD drugs: oversold and overused - Baltimore Sun

ADHD drugs: oversold and overused
Baltimore Sun, United States -Aug 23, 2007
This month's homemaker-targeted magazines, such as Family Circle, Woman's Day and Redbook, feature advertising spreads for Vyvanse, Shire US Inc.'s new ...

...

Modest launch seen so far for Shire drug Vyvanse - Reuters.uk

Mon, 03 Sep 2007 23:15:47 +0000

Modest launch seen so far for Shire Vyvanse
Reuters.uk, UK -Aug 23, 2007
L: Quote, Profile , Research) new hyperactivity drug Vyvanse has had a modest launch so far in the United States, partly reflecting the school holiday ...

Shire’s New ADHD medication, VYVANSE™ (lisdexamfetamine dimesylate ... - HealthNewsDigest.com

HealthNewsDigest.com

Shire’s New ADHD medication, VYVANSE™ (lisdexamfetamine dimesylate ...
HealthNewsDigest.com, NY -

Modest launch seen so far for Shire drug Vyvanse

Sat, 25 Aug 2007 23:18:22 +0000

Reuters - LONDON, Aug 23 (Reuters) - Shire Plc's (SHP.L: Quote , Profile , Research ) new hyperactivity drug Vyvanse has had a modest launch so far in the United States, partly reflecting the school holiday period, according to industry analysts. A spokesman ...

Nagging credit concerns rein back early gains
Guardian Unlimited - Prescription data for its key new drug to treat attention deficit hyperactivity disorder (ADHD) - Vyvanse - in the nine weeks since its launch, is "encouraging", according to analysts at Citigroup . They said: "We expect trends to strengthen ...

It's Time To Choose Back-To-School Meds!
Hartford Courant - This month's homemaker-targeted magazines, such as Family Circle, Woman's Day and Redbook, feature advertising spreads for Vyvanse, Shire US Inc.'s new entry in the growing stable of ADHD medications. The ads show "Consistent Kevin through the day ...

Ty's 'Project Playground'
ETOnline.com - The unveiling of "Project Playground" also celebrates the launch of Vyvanse, Shire's newest ADHD treatment for children. "If they do have ADHD, maybe they'll be diagnosed at an early age, because it really affects the rest of your life," says Ty ...

The following is a Sponsored Resource . The sponsor of this content ...
WebMD - Vyvanse has been shown to provide consistent ADHD symptom control for up to 12 hours – from school to homework and family time. In a clinical study with Vyvanse, parents reported that their children's ADHD symptoms were controlled at approximately ... ...

Vyvanse Information from Drugs.com

Sat, 25 Aug 2007 00:15:32 +0000

Vyvanse information from Drugs.com, includes Vyvanse side effects, interactions and indications. ... Do not use Vyvanse if you have used an MAO inhibitor such ...

Vyvanse
Vyvanse, Attention Deficit Disorder, Vyvanse is a new medication that has been approved by the ... ADD Primer Related Conditions Medications Therapies FAQ and ...

Vyvanse ADHD Treatment: from the makers of Adderall XR
Once-daily medication for the treatment of ADHD and ADD. From Shire.

medication guide
... the Medication Guide that comes with Vyvanse before you or your child starts ... taking Vyvanse, especially seeing or hearing things that ...

DEA schedules VYVANSE, clearing way for launch of first prodrug stimulant ADHD treatment
... Administration has classified Shire's VYVANSE as a Schedule II controlled ... New Drug Application (NDA) for VYVANSE for the treatment of Attention Deficit ......

Vyvanse Watch

Thu, 23 Aug 2007 00:18:30 +0000

Vyvanse (lisdexamfetamine dimesylate) was approved by the FDA in February for the treatment of ADHD in children, and is finally available in pharmacies. Tonight, Shire is presenting its official introduction of Vyvanse to physicians in ...

Vyvanse
Vyvanse is an extremely interesting new treatment for ADHD that has just been approved by the FDA and should be available in the United States in the very near future. It is manufactured by Shire Pharmaceuticals that is getting a ...

Vyvanse - Now Available Across the USA
Vyvanse, also known as lisdexamfetamine dimesylate, is the newest addition of medications available to treat the common Attention Deficit Hyperactivity Disorder (or Attention Deficit Disorder). Vyvanse is a ‘pro-drug’, which means that ...

Shire submits Vyvanse sNDA for adult ADHD
After launching Vyvanse (lisdexamfetamine dimesylate) last month, Shire submits a supplemental claim for treatment of attention deficit/hyperactivity disorder in adults, the firm announces June 29. The sNDA will receive a standard ...

More News About Vyvanse
Earlier I’ve written about Vyvanse (lisdexamfetamine dimesylate, or LDX), the interesting new central nervous system stimulant. It’sa comboination of dextroamphetamine and lysine, an amino acid. There’s more to report on this new ......

Are These Perfect Pharma Acquisitions' (The Motley Fool)

Wed, 22 Aug 2007 23:15:44 +0000

Weighing recent drug-industry deals' odds of success.

Celebrity Designer Ty Pennington Partners with Shire to Unveil Project Playground in New York Harlem Neighborhood (PR Newswire via Yahoo! Finance)
Celebrity designer Ty Pennington today will unveil Project Playground, a community-centered initiative in which Pennington has partnered with Shire to design, build and donate a fully equipped playground to an elementary school in the Harlem neighborhood of New York City, Public School 72.

Shire's New ADHD Medication, VYVANSE(TM) (lisdexamfetamine dimesylate) Now Available in U.S. Pharmacies Nationwide (PR Newswire via Yahoo! Finance)
Shire plc announced today that VYVANSE , a new once-daily medication approved to treat the symptoms of Attention Deficit Hyperactivity Disorder , is now available in U.S. pharmacies nationwide.

Shire's new ADHD medication now available (Pharmaceutical Business Review)
Shire says Vyvanse, its once-daily medication approved to treat the symptoms of attention deficit hyperactivity disorder, is now available in US pharmacies nationwide.

AMRI Announces Second Quarter Results (Business Wire via Yahoo! Finance)
ALBANY, N.Y.----AMRI today reported strong earnings growth driven by increased milestone and royalty revenue, revenue growth in both the Discovery Services and Development/Small Scale contract services business components, and continued improvement in gross margin in Large Scale Manufacturing....

Does Vyvanse Work'

Wed, 22 Aug 2007 00:15:44 +0000

Please type in any of your own personal experiences with Vyvanse so that the readers of this blog can benefit from your knowledge and experience. I know that the readers of this blog span the whole globe - so if you have experience with ...

Vyvanse - The New Medicine for ADD/ADHD
Vyvanse is a new ADD/ADHD drug manufactured by Shire that was approved by the FDA in February 2007 to treat ADD/ADHD symptoms in children aged 6 through 12. It is a prodrug, which means that it must be orally ingested to activate its ...

Shire gearing up for Vyvanse launch
Shire has amassed a 560-person sales force in advance of its Monday launch of new attention deficit hyperactivity drug Vyvanse.

Vyvanse Available in Pharmacies
In a clinical study, VYVANSE provided consistent ADHD symptom control throughout the day based upon parent reports in the morning (approximately 10am), afternoon (approximately 2pm), and early evening (approximately 6pm). ...

Vyvanse: No Addiction with ADD/ADHD Medication
What’s the difference with Vyvanse' Because Vyvanse is a ‘pro-drug’, it cannot be abused. A pro-drug means that the active medicine is bound to a protein, so it doesn’t work as an amphetamine when it is first taken. ......

Shire's New ADHD medication, VYVANSE(TM) (lisdexamfetamine dimesylate) Now Available in U.S. Pharmacies Nationwide (FinanzNachrichten)

Tue, 21 Aug 2007 23:24:28 +0000

PHILADELPHIA, July 27 /PRNewswire-FirstCall/ -- Shire plc ( Nachrichten ) (LSE: SHP; NASDAQ: SHPGY; TSX: SHQ) announced today that VYVANSE (lisdexamfetamine dimesylate), a new once-daily medication approved to treat the symptoms of Attention Deficit Hyperactivity Disorder (ADHD), is now available in U.S. pharmacies nationwide.

Shire ups revenue forecast as new drugs shine (Reuters.co.uk)
LONDON (Reuters) - Shire nudged up its 2007 revenue growth forecast on Thursday, boosted by a string of drug launches, and said its biggest new hope, Vyvanse for hyperactivity, had made a particularly strong start.

Shire's Got Focus: Fool by Numbers (The Motley Fool)
Fast facts the Fool way.

Shire Reports $1.81 Billion Loss After Acquisition (Update1) (Bloomberg.com)
July 26 (Bloomberg) -- Shire Plc, the U.K.'s third-largest drugmaker, reported a second-quarter loss after the company wrote down assets acquired in the purchase of New River Pharmaceuticals Inc. The company raised its forecast for revenue growth this year.

Shire eyes regenerative surgery market (Daily Telegraph)
Shire, the UK's third biggest drugs maker, wants to expand its footprint in the "regenerative surgery" market after striking a licensing deal over a scar repair drug last month....

Vyvanse Information from Drugs.com

Tue, 21 Aug 2007 13:01:35 +0000

Vyvanse information from Drugs.com, includes Vyvanse side effects, interactions and indications. ... Do not use Vyvanse if you have used an MAO inhibitor such ...

Vyvanse for ADHD
Vyvanse for ADHD, Pediatrics, Vyvanse is a new FDA approved treatment for ADHD in children. ... What makes Vyvanse different' Vyvanse is a prodrug that is ...

Vyvanse
Vyvanse, Attention Deficit Disorder, Vyvanse is a new medication that has been approved by the ... ADD Primer Related Conditions Medications Therapies FAQ and ...

medication guide for vyvanse (lisdexamfetamine dimesylate)
... the Medication Guide that comes with Vyvanse before you or your child starts ... taking Vyvanse, especially seeing or hearing things that ...

FDA approves first and only stimulant prodrug VYVANSE as a novel ADHD treatment
... marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known ... VYVANSE is a prodrug that is therapeutically inactive until metabolized in the body. ......

Vyvanse

Mon, 20 Aug 2007 23:16:12 +0000

Vyvanse (lisdexamfetamine dimesylate) is designed as a capsule for once-a-day oral ... Scale (ADHD-RS), were observed at endpoint for all Vyvanse doses ...

Shire Receives Approval Letter for VYVANSE_ (lisdexamfetamine dimesylate) for the Treatment of ADHD
... are pleased with the results of VYVANSE studies conducted in adults and we ... VYVANSE is a priority in our ADHD portfolio and we are committed to developing ...

Vyvanse Long Acting ADHD Medication Coming Soon
Vyvanse (lisdexamfetamine dimesylate) coming soon for the treatment of ADHD, providing consistent ADHD symptom control for children for up to 12 hours.

Vyvanse
Vyvanse, an FDA-approved treatment for children with ADHD, became available in July 2007. ... Childhood Medications> Drug Profiles> ADHD Medicines> Vyvanse ...

ADHD Resources and Support - Vyvanse
A list of our favorite resources to help your child's unique talents and abilities consistently shine through. ... Already taking Vyvanse' ......

Celebrity Designer Ty Pennington Partners with Shire to Unveil Project ...

Thu, 09 Aug 2007 00:15:46 +0000

Forbes - Shire is the leading manufacturer of ADHD medications, including the newly launched VYVANSE(TM) (lisdexamfetamine dimesylate). For further information on Project Playground please contact: Brooke Salti (Porter Novelli for Shire) (212) 601-8241 ...

The following is a Sponsored Resource . The sponsor of this content ...
WebMD - Vyvanse has been shown to provide consistent ADHD symptom control for up to 12 hours – from school to homework and family time. In a clinical study with Vyvanse, parents reported that their children's ADHD symptoms were controlled at approximately ...

A slow year so far for innovative drugs
LabTechnologist.com - New River Pharmaceuticals' (now acquired by Shire) Vyvanse (lisdexamfetamine) for Attention Deficit Hyperactivity Disorder (ADHD); Tekturna (Aliskiren) from Novartis and Speedel, which treats hypertension; another high blood pressure drug from Gilead ...

Brokers' reports help offset housebuilder dip
Guardian Unlimited - JP Morgan said the company could underperform in terms of being able to successfully switch patients from Adderall XR, its attention deficit hyperactivity disorder treatment, to its new product Vyvanse. "There is real downside risk if Shire fails to ... ...

Shire's New ADHD medication, VYVANSE(TM) (lisdexamfetamine ... - CNNMoney.com

Wed, 08 Aug 2007 00:16:00 +0000

Shire's New ADHD medication, VYVANSE(TM) (lisdexamfetamine ...
CNNMoney.com -Jul 27, 2007
In a clinical study, VYVANSE provided consistent ADHD symptom control throughout the day based upon parent reports in the morning (approximately 10am), ...

Shire CEO says Vyvanse launch going extremely well - Reuters.uk

Shire CEO says Vyvanse launch going extremely well
Reuters.uk, UK -Jul 26, 2007
Chief Executive Matthew Emmens told reporters that in three weeks the firm had seen around 15000 promotional coupons for Vyvanse taken to pharmacies and ...

New ADHD Medication VYVANSE Now Available - eMaxHealth.com

New ADHD Medication VYVANSE Now Available
eMaxHealth.com, NC -Jul 28, 2007
Shire plc's VYVANSE , a new once-daily ...

More News About Vyvanse

Mon, 06 Aug 2007 23:15:37 +0000

Earlier I’ve written about Vyvanse (lisdexamfetamine dimesylate, or LDX), the interesting new central nervous system stimulant. It’sa comboination of dextroamphetamine and lysine, an amino acid. There’s more to report on this new ...

Vyvanse - The New Medicine for ADD/ADHD
Vyvanse is a new ADD/ADHD drug manufactured by Shire that was approved by the FDA in February 2007 to treat ADD/ADHD symptoms in children aged 6 through 12. It is a prodrug, which means that it must be orally ingested to activate its ...

Shire gearing up for Vyvanse launch
Shire has amassed a 560-person sales force in advance of its Monday launch of new attention deficit hyperactivity drug Vyvanse.

Vyvanse
Vyvanse is an extremely interesting new treatment for ADHD that has just been approved by the FDA and should be available in the United States in the very near future. It is manufactured by Shire Pharmaceuticals that is getting a ...

Vyvanse: No Addiction with ADD/ADHD Medication
What’s the difference with Vyvanse' Because Vyvanse is a ‘pro-drug’, it cannot be abused. A pro-drug means that the active medicine is bound to a protein, so it doesn’t work as an amphetamine when it is first taken. ......

A slow year so far for innovative drugs

Sun, 05 Aug 2007 23:15:45 +0000

LabTechnologist.com - New River Pharmaceuticals' (now acquired by Shire) Vyvanse (lisdexamfetamine) for Attention Deficit Hyperactivity Disorder (ADHD); Tekturna (Aliskiren) from Novartis and Speedel, which treats hypertension; another high blood pressure drug from Gilead ...

Brokers' reports help offset housebuilder dip
Guardian Unlimited - JP Morgan said the company could underperform in terms of being able to successfully switch patients from Adderall XR, its attention deficit hyperactivity disorder treatment, to its new product Vyvanse. "There is real downside risk if Shire fails to ... ...

Shire's new ADHD medication now available - Pharmaceutical Business Review

Sun, 05 Aug 2007 00:15:47 +0000

Shire's new ADHD medication now available
Pharmaceutical Business Review -Jul 31, 2007
By Staff Writer Shire says Vyvanse, its once-daily medication approved to treat the symptoms of attention deficit hyperactivity disorder, is now available ...

Shire eyes regenerative surgery market - Telegraph.co.uk

Shire eyes regenerative surgery market
Telegraph.co.uk, United Kingdom -Jul 26, 2007
The company said the launch of Vyvanse, its latest product for attention deficit, had exceeded expectations. Vyvanse is the first slow-release ADHD product ...

Shire Reports $1.81 Billion Loss After Acquisition (Update1) - Bloomberg

Shire Reports $1.81 Billion Loss After Acquisition (Update1)
Bloomberg -Jul 26, 2007
Shire in April paid $2.6 billion for partner New Ri...

AMRI Announces Second Quarter Results

Sat, 04 Aug 2007 23:15:22 +0000

TMCnet - ... to achieve anticipated revenues and earnings, costs related to the acquisition and any goodwill impairment related to such investments and acquisitions, the risks posed by international operations to the company, the commercial success of Vyvanse(TM ...

A slow year so far for innovative drugs
LabTechnologist.com - New River Pharmaceuticals' (now acquired by Shire) Vyvanse (lisdexamfetamine) for Attention Deficit Hyperactivity Disorder (ADHD); Tekturna (Aliskiren) from Novartis and Speedel, which treats hypertension; another high blood pressure drug from Gilead ...

Brokers' reports help offset housebuilder dip
Guardian Unlimited - JP Morgan said the company could underperform in terms of being able to successfully switch patients from Adderall XR, its attention deficit hyperactivity disorder treatment, to its new product Vyvanse. "There is real downside risk if Shire fails to ... ...

New ADHD Drug available - WKYC-TV

Sun, 29 Jul 2007 03:15:31 +0000

New ADHD Drug available
WKYC-TV, OH -Jul 25, 2007
Earlier this year the FDA approved Vyvanse, a once-daily treatment that provides consistent ADHD symptom control. According to the manufacturer, Shire plc, ...

Shire raises annual revenue guidance; Q2 underlying earnings rise ... - Hemscott

Shire raises annual revenue guidance; Q2 underlying earnings rise ...
Hemscott, UK -Jul 26, 2007
Shire bought New River Pharmaceuticals earlier this year for 2.6 bln usd, to give it full ownership of new hyperactivity pill Vyvanse. ...

VYVANSE(TM) Drug for the Treatment of ADHD in Adults - MedIndia

VYVANSE(TM) Drug for the Treatment of ADHD in Adults
MedIndia, India -Jul 3, 2007
"We are pleased with the results of VYVANSE studies conducted in adults and we believe this prod...

Vyvanse Information from Drugs.com

Sun, 29 Jul 2007 00:17:22 +0000

Vyvanse information from Drugs.com, includes Vyvanse side effects, interactions and indications. ... Do not use Vyvanse if you have used an MAO inhibitor such ...

Vyvanse
Vyvanse, Attention Deficit Disorder, Vyvanse is a new that has been approved by the ... ADD Primer Related Conditions Medications Therapies FAQ and ...

Vyvanse ADHD Treatment: from the makers of Adderall XR
Once-daily medication for the treatment of ADHD and ADD. From Shire.

medication guide for vyvanse (lisdexamfetamine dimesylate)
... the Medication Guide that comes with Vyvanse before you or your child starts ... taking Vyvanse, especially seeing or hearing things that ...

FDA approves first and only stimulant prodrug VYVANSE as a novel ADHD treatment
... marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known ... VYVANSE is a prodrug that is therapeutically inactive until metabolized in the body. ......

Shire eyes regenerative surgery market (Daily Telegraph)

Sat, 28 Jul 2007 16:52:15 +0000

Shire, the UK's third biggest drugs maker, wants to expand its footprint in the "regenerative surgery" market after striking a licensing deal over a scar repair drug last month.

FTSE dives on credit woes and results (Interactive Investor)
Business Finance and city news online from Interactive Investor (www.iii.co.uk). Plus financial and currency market news and information 24/7. Stock prices, share prices, currency markets news and business finance headlines. Also news from AFX and Reuters.

FTSE at near four-month low on credit woes (Tiscali)
The FTSE 100 ended down 203.1 points, or 3.2 percent, at 6,251.2 to their lowest close since in almost four months. Banking and mining sectors were worst hit by the economic jitters, with HBOS down 3.1 percent and Northern Rock falling 5.8 percent.

Global stocks slide (Stuff)
The FTSE 100 of leading shares slid by the biggest one-day per centage since March 2003 on Thursday as a flurry of corporate results failed to offset losses driven by concerns over a US credit crisis.

FTSE at near four-month low (Reuters via Yahoo! UK & Ireland Finance)
The FTSE 100 <.FTSE> of leading shares slid by the biggest one-day percentage since March 2003 on Thursday as a flurry of corporate results failed to offset losses driven by concerns over a U.S. credit crisis....